Ogihara T, Mikami H
Department of Geriatric Medicine, Osaka University Medical School.
Rinsho Byori. 1990 May;38(5):559-62.
Many hypotheses have been advocated to explain the pathogenesis of essential hypertension: Guyton's autoregulation theory, the natriuretic hormone theory represented by de Wardner, the sympathetic nervous system theory, and the genetic theory etc. However, none of these theories alone explain the single etiology of hypertension and as stated in Page's Mosaic theory, complicated interaction of many factors has been implicated. We have performed a series of studies to evaluate the interaction between the pressor and depressor systems in relation to salt balances and found in general that hyperfunction of the pressor system and the reduced activity of the depressor systems exist in essential hypertension. Many substances also have been found to be involved in the blood pressure regulation and recently endothelin, a most potent pressor peptide which derives from endothelial cell, was discovered and synthesized by Yanagisawa et al. and its pathophysiological roles are now being extensively investigated. On the other hand, the development of many antihypertensive drugs with different modes of action has enabled us to individualize the treatment of hypertension. Further development of drugs with fewer adverse side effects, whether symptomatic or of abnormality in the clinical laboratory data, and which can maintain or even improve the quality of life is mandatory to pursue life-long treatment of hypertension for successful prevention of the fatal vascular complications.
如盖顿的自动调节理论、以德·瓦德纳为代表的利钠激素理论、交感神经系统理论以及遗传理论等。然而,这些理论中没有一个能单独解释高血压的单一病因,正如佩奇的镶嵌理论所述,许多因素之间存在复杂的相互作用。我们进行了一系列研究,以评估升压系统和降压系统之间与盐平衡相关的相互作用,总体发现原发性高血压中存在升压系统功能亢进和降压系统活性降低的情况。人们还发现许多物质参与血压调节,最近,柳泽等人发现并合成了内皮素,这是一种由内皮细胞产生的最强效升压肽,目前其病理生理作用正在被广泛研究。另一方面,许多具有不同作用方式的抗高血压药物的开发,使我们能够对高血压进行个体化治疗。进一步开发副作用更少的药物,无论是症状性的还是临床实验室数据异常方面的副作用,并且能够维持甚至改善生活质量,对于高血压的终身治疗以成功预防致命的血管并发症来说是必不可少的。